Intravascular molecular imaging: translating pathophysiology of atherosclerosis into human disease conditions
- PMID: 36002376
- DOI: 10.1093/ehjci/jeac163
Intravascular molecular imaging: translating pathophysiology of atherosclerosis into human disease conditions
Abstract
Progression of atherosclerotic plaque in coronary arteries is characterized by complex cellular and non-cellular molecular interactions. Within recent years, atherosclerosis has been recognized as inflammation-driven disease condition, where progressive stages are characterized by morphological changes in plaque composition but also relevant molecular processes resulting in increased plaque vulnerability. While existing intravascular imaging modalities are able to resolve key morphological features during plaque progression, they lack capability to characterize the molecular profile of advanced atherosclerotic plaque. Because hybrid imaging modalities may provide incremental information related to plaque biology, they are expected to provide synergistic effects in detecting high risk patients and lesions. The aim of this article is to review existing literature on intravascular molecular imaging approaches, and to provide clinically oriented proposals of their application. In addition, we assembled an overview of future developments in this field geared towards detection of patients at risk for cardiovascular events.
Keywords: coronary artery; near-infrared fluorescence; near-infrared spectroscopy; photoacoustic; vulnerable plaque.
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Conflict of interest statement
Conflict of interest: M.J. reports personal fees from Abbott, Orbus Neich, Astra Zeneca, Recor, Schockwave, grants and personal fees from Biotronik, Boston Scientific, Cardiac dimensions, Edwards Lifesciences and grant support from Infraredx outside the submitted work. MJ has received funding from the German Center for Cardiovascular Research: DZHK (FKZ 81Z0600502; FKZ 81X2600526) and from the Leducq Foundation (grant agreement number 18CVD02). F.J. has received sponsored research from Kowa, Boston Scientific, Mercator, Canon, Siemens, Teleflex, Heartflow and Shockwave and is a consultant for Boston Scientific, Abbott Vascular, Siemens, Magenta Medical, Asahi Intecc, Philips, Biotronik, and IMDS. F.J. has an equity interest in Intravascular Imaging, Inc. and DurVena. Massachusetts General Hospital has a patent licensing arrangement with Terumo, Canon, and SpectraWAVE; F.J. (Terumo, Canon, SpectraWAVE) have the right to receive royalties. V.N. is a founder and equity owner of sThesis GmbH, iThera Medical GmbH, of Spear UG and of I3 Inc. The other authors report no conflict of interest.
Similar articles
-
In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.J Vis Exp. 2011 Aug 4;(54):2257. doi: 10.3791/2257. J Vis Exp. 2011. PMID: 21847078 Free PMC article.
-
Intravascular multimodality imaging: feasibility and role in the evaluation of coronary plaque pathology.Eur Heart J Cardiovasc Imaging. 2017 Jun 1;18(6):613-620. doi: 10.1093/ehjci/jew330. Eur Heart J Cardiovasc Imaging. 2017. PMID: 28329320 Review.
-
Reliable in vivo intravascular imaging plaque characterization: A challenge unmet.Am Heart J. 2019 Dec;218:20-31. doi: 10.1016/j.ahj.2019.07.008. Epub 2019 Jul 23. Am Heart J. 2019. PMID: 31655414 Review.
-
Assessment of plaque composition by intravascular ultrasound and near-infrared spectroscopy: from PROSPECT I to PROSPECT II.Circ J. 2014;78(7):1531-9. doi: 10.1253/circj.cj-14-0496. Epub 2014 Jun 16. Circ J. 2014. PMID: 24931516 Review.
-
Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology.Eur Heart J. 2017 Feb 7;38(6):400-412. doi: 10.1093/eurheartj/ehw097. Eur Heart J. 2017. PMID: 27118197 Free PMC article. Review.
Cited by
-
Dual modality intravascular catheter system combining pulse-sampling fluorescence lifetime imaging and polarization-sensitive optical coherence tomography.Biomed Opt Express. 2024 Mar 5;15(4):2114-2132. doi: 10.1364/BOE.516515. eCollection 2024 Apr 1. Biomed Opt Express. 2024. PMID: 38633060 Free PMC article.
-
Evaluation the role of cuproptosis-related genes in the pathogenesis, diagnosis and molecular subtypes identification of atherosclerosis.Heliyon. 2023 Oct 18;9(10):e21158. doi: 10.1016/j.heliyon.2023.e21158. eCollection 2023 Oct. Heliyon. 2023. PMID: 37928399 Free PMC article.
-
Intravascular ICG-enhanced NIRF-IVUS imaging to assess progressive atherosclerotic lesions in excised human coronary arteries.NPJ Cardiovasc Health. 2024;1(1):14. doi: 10.1038/s44325-024-00016-8. Epub 2024 Aug 30. NPJ Cardiovasc Health. 2024. PMID: 39246665 Free PMC article.
-
Co-Delivery of Therapeutics and Bioactive Gas Using a Novel Liposomal Platform for Enhanced Treatment of Acute Arterial Injury.Biomolecules. 2023 May 19;13(5):861. doi: 10.3390/biom13050861. Biomolecules. 2023. PMID: 37238730 Free PMC article.
-
A Cross-talk between Nanomedicines and Cardiac Complications: Comprehensive View.Curr Pharm Des. 2025;31(10):741-752. doi: 10.2174/0113816128347223241021111914. Curr Pharm Des. 2025. PMID: 39506444 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical